Visual Field Digest Teaching Kit Chapter 8 HAAGSTREIT

Visual Field Digest Teaching Kit Chapter 8 HAAG-STREIT AG

Teaching Kit Copyright § The Visual Field Digest Teaching Kit includes all figures and illustrations from the Visual Field Digest. They can be used for non-commercial presentations free of charge. § Haag-Streit AG allows the use of this figures for personal or academic use under the conditions that § (i) it is used without commercial purpose and § (ii) the content is reproduced exactly as the original by mentioning Haag-Streit AG, Switzerland as the owner of the copyright. § Non-academic, non-personal or commercial users might only use this figures in whole or in part after a written authorization by the copyright holder. § “Haag-Streit”, “ 900” and “Octopus” are either registered trademarks or trademarks of Haag-Streit Holding AG. § The following are either registered trademarks or trademarks of Carl Zeiss Meditec: “Guided Progression Analysis”, “GPA”, “Humphrey”, “HFA”, “SITA Fast”, “SITA Standard”, “Visual Field Index”, and “VFI”. § Copyright © 2018 HAAG-STREIT AG

Fig. 8 -1 -1: Visual field interpretation examples

Fig. 8 -1 -2: Visual field interpretation examples

Fig. 8 -1 -3: Visual field interpretation examples

Fig. 8 -2: Visual field interpretation workflow

Fig. 8 -3: Step 1 – Confirm patient and examination parameters

Fig. 8 -4: Overview of patient and examination parameters

Fig. 8 -5: Step 2 – Asses whether the visual field can be trusted

Fig. 8 -6: Untrustworthy visual field tests can show significant defects

Fig. 8 -7: Impact of false positive answers on visual field result

Fig. 8 -8: Impact of false negative answers on visual field result

Fig. 8 -9: Step 3 – Identify diffuse visual field loss

Fig. 8 -10: Defect Curve – Interpretation aid

Fig. 8 -11: Example of the clinical usefulness of the Defect Curve

Fig. 8 -12: Example of the clinical usefulness of the corrected representations

Fig. 8 -13: Step 4 – Distinguish between normal and abnormal visual fields

Fig. 8 -14: Probabilities and Corrected Probabilities – Interpretation aid

Fig. 8 -15: Clinical interpretation of Probabilities in borderline situations

Fig. 8 -16: Limitations of the Probabilities representation in advanced disease

Fig. 8 -17: Step 5 – Assess shape and depth of defect

Fig. 8 -18: Grayscale of Comparisons, Comparisons and Corrected Comparisons – Interpretation aid

Fig. 8 -19: Step 6 – Assess cluster defects in glaucoma

Fig. 8 -20: Cluster Analysis and Corrected Cluster Analysis –Interpretation aid

Fig. 8 -21: Illustration of the high sensitivity of Cluster Analysis to detect glaucoma

Fig. 8 -22: Step 7 – Where to look for structural defects

Fig. 8 -23: Polar Analysis – Interpretation aid

Fig. 8 -24: Illustration of the clinical usefulness of the Polar Analysis

Fig. 8 -25: Step 8 – Assess visual field severity

Fig. 8 -26: Step 8 – Illustration of the usefulness of MD

Fig. 8 -27: Illustration of the usefulness of s. LV

Table 8 -1: The etiology of diffuse and local visual field defects

Box 8 A: Grayscale representations are interpolated color maps

Box 8 B: Illustration of the clinical usefulness of Cluster Analysis

Box 8 C: Spatial relationship between visual fields and structural results